Latka logo
Genezen logo

Genezenrevenue & acquisition

Indianapolis, IndianaFounded 2014

Genezen was acquired.

Genezen is a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in viral vector manufacturing services.

genezen.comLinkedInUpdated Sep 10, 2026
Annual revenue
$48M
Sep 2024EST
Owner
Undisclosed
Date not on record

Genezen revenue

Genezen has not published its revenue. Growjo puts it at about $48M a year (September 2024).

$0
$20M
$40M
$0
–
$48M
20142015–232024
ReportedEstimateFounded 2014 at $0; every reading has its own bar
As ofRevenueSource
Sep 2024$48MESTGrowjo estimate

Who owns Genezen

Another company owns Genezen. The date and price of the deal are not on record.

Categories

How this page is sourced

1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Genezen? Join the podcast